Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Júlia Stark

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Orvosi Hetilap|July 8, 2015
[Oxidative stress and atherosclerosis]Júlia Stark
Frontiers in Oncology|May 28, 2021
Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive MarkersJudit Tőke, Zsuzsanna Jakab, Júlia Stark, et al.
Annales D'Endocrinologie|July 27, 2023
Parathyroid cancer with MTOR gene mutation: Case report and review of the literatureJúlia Stark, Judit Tőke, Gergely Huszty, et al.
Frontiers in Endocrinology|October 17, 2022
Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case seriesJudit Tőke, Andrea Uhlyarik, Júlia Lohinszky, et al.
Annals of Clinical Microbiology and Antimicrobials|July 9, 2014
The effect of indomethacin, myeloperoxidase, and certain steroid hormones on bactericidal activity: an ex vivo and in vivo experimental studyJúlia Stark, Zsuzsanna Varga, Ágoston Ghidán, et al.
The Lancet. Diabetes & Endocrinology|November 14, 2025
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort studyElisabeth Nowak, Qilin Zhang, Shuo Zhang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Orvosi Hetilap|July 8, 2015
[Oxidative stress and atherosclerosis]Júlia Stark
Frontiers in Oncology|May 28, 2021
Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive MarkersJudit Tőke, Zsuzsanna Jakab, Júlia Stark, et al.
Annales D'Endocrinologie|July 27, 2023
Parathyroid cancer with MTOR gene mutation: Case report and review of the literatureJúlia Stark, Judit Tőke, Gergely Huszty, et al.
Frontiers in Endocrinology|October 17, 2022
Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case seriesJudit Tőke, Andrea Uhlyarik, Júlia Lohinszky, et al.
Annals of Clinical Microbiology and Antimicrobials|July 9, 2014
The effect of indomethacin, myeloperoxidase, and certain steroid hormones on bactericidal activity: an ex vivo and in vivo experimental studyJúlia Stark, Zsuzsanna Varga, Ágoston Ghidán, et al.
The Lancet. Diabetes & Endocrinology|November 14, 2025
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort studyElisabeth Nowak, Qilin Zhang, Shuo Zhang, et al.
Pageof 1